Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma ...Middle East

KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union PETACH TIKVAH, Israel, June 8, 2022 /PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company...

Hence then, the article about medison pharma announces the approvals by health canada and therapeutics goods administration of kimmtrak tebentafusp for the treatment of unresectable or metastatic uveal melanoma was published today ( Wednesday 08/06/2022 - 06:49 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma )

Also on site :

• Drew Barrymore's Buttercream-Yellow Walmart Kitchen Collection Is the Summery Refresh Your Space Needs
• ABBA’s Björn Ulvaeus Talks AI Training at United Nations Summit: Artists ‘Deserve a Place at the Table’
• Olympic Gymnastics Legend, Who Scored the World’s First Perfect 10, Relives Her Greatest Performance 50 Years Later